Halozyme Therapeutics, Inc. HALO
122.96 USD -7.38 (-5.66%)
At closeNov 5, 2026, 7:47 PM EST
114.02 -8.94 -7.27%
After hours · Nov 5, 7:47 PM ET
122.77 Day range 131.44
61.23 52-week range 134.00
- YTD
- +82.70%
- 1 year
- +80.03%
Held by funds
278 US ETFs and mutual funds hold HALO · largest positions
Ownership
Held by insiders 1.08%
Held by institutions 113.55%
Float held by institutions 114.80%
Institutions 962
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 11.69% | 13,271,095 | 1.73B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.71% | 5,351,312 | 697.49M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.67% | 5,299,008 | 690.67M | Jun 29, 2026 |
| State Street Corporation | 4.56% | 5,179,434 | 675.09M | Jun 29, 2026 |
| Invesco Ltd. | 2.80% | 3,177,997 | 414.22M | Jun 29, 2026 |
| Morgan Stanley | 2.50% | 2,832,594 | 369.20M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 4,042,836 | 526.94M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.32% | 3,762,787 | 490.44M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.40% | 2,721,119 | 354.67M | Jun 29, 2026 |
| John Hancock Funds III-Disciplined Value Mid Cap Fund | 1.48% | 1,679,285 | 218.88M | Aug 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.38% | 1,566,912 | 204.23M | Jun 29, 2026 |
| AIM Counselor Series TRT -Invesco Discovery Fd. | 1.22% | 1,382,875 | 180.24M | Aug 30, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CONNAUGHTON BERNADETTE M. | Director | Sale | Aug 9, 2026 | 40,418 |
| DUNCAN BARBARA GAYLE | Director | Stock Award(Grant) | May 4, 2026 | 23,715 |
| HENDERSON JEFFREY WILLIAM | Director | Stock Award(Grant) | May 4, 2026 | 36,572 |
| LABARRE MICHAEL J. | Chief Technology Officer | Sale | Feb 26, 2025 | 173,756 |
| LABROSSE NICOLE | Chief Financial Officer | Conversion of Exercise of derivative security | Feb 22, 2026 | 38,494 |
| MATSUI CONNIE L | Director | Stock Gift | Nov 28, 2024 | 183,035 |